258 related articles for article (PubMed ID: 37335089)
1. Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing.
Wang H; Han G; Chen J
Aging (Albany NY); 2023 Jun; 15(12):5339-5354. PubMed ID: 37335089
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma.
Lu H; Qian J; Cheng L; Shen Y; Chu T; Zhao C
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38081768
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
4. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma.
Chen Z; Huang Y; Hu Z; Zhao M; Li M; Bi G; Zheng Y; Liang J; Lu T; Jiang W; Xu S; Zhan C; Xi J; Wang Q; Tan L
Clin Transl Med; 2021 Mar; 11(3):e350. PubMed ID: 33783985
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome characteristics of epithelial cells from advanced non-small cell lung cancer were revealed by single-cell RNA sequencing.
Qiu P; Chen Y; Dong C; Xie J; Wang J
Environ Toxicol; 2024 Feb; 39(2):723-735. PubMed ID: 37676967
[TBL] [Abstract][Full Text] [Related]
6. T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing.
Zhang J; Liu X; Huang Z; Wu C; Zhang F; Han A; Stalin A; Lu S; Guo S; Huang J; Liu P; Shi R; Zhai Y; Chen M; Zhou W; Bai M; Wu J
Comput Biol Med; 2023 Jan; 152():106460. PubMed ID: 36565482
[TBL] [Abstract][Full Text] [Related]
7. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956
[TBL] [Abstract][Full Text] [Related]
8. Integrating bulk-RNA sequencing and single-cell sequencing analyses to characterize adenosine-enriched tumor microenvironment landscape and develop an adenosine-related prognostic signature predicting immunotherapy in lung adenocarcinoma.
Han T; Wu J; Liu Y; Zhou J; Miao R; Guo J; Xu Z; Xing Y; Bai Y; Hu D
Funct Integr Genomics; 2024 Jan; 24(1):19. PubMed ID: 38265702
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time.
Liu D; Yao L; Ding X; Zhou H
Comput Biol Med; 2023 Sep; 164():107333. PubMed ID: 37586202
[TBL] [Abstract][Full Text] [Related]
10. Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature.
Zhang P; Zhang X; Cui Y; Gong Z; Wang W; Lin S
Front Immunol; 2023; 14():1244144. PubMed ID: 37671160
[TBL] [Abstract][Full Text] [Related]
11. Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma.
Tang L; Chen Z; Yang J; Li Q; Wang S; Mo T; Zeng W; Ding H; Pan S
Front Immunol; 2024; 15():1352893. PubMed ID: 38390340
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
13. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J
Front Immunol; 2023; 14():1217590. PubMed ID: 37492563
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
Xiao G; Li L; Tanzhu G; Liu Z; Gao X; Wan X; Xiao D; Chen L; Xia X; Zhou R
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868569
[TBL] [Abstract][Full Text] [Related]
15. The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing.
Wang C; Yu Q; Song T; Wang Z; Song L; Yang Y; Shao J; Li J; Ni Y; Chao N; Zhang L; Li W
Signal Transduct Target Ther; 2022 Aug; 7(1):289. PubMed ID: 36008393
[TBL] [Abstract][Full Text] [Related]
16. Immune and non-immune cell subtypes identify novel targets for prognostic and therapeutic strategy: A study based on intratumoral heterogenicity analysis of multicenter scRNA-seq datasets in lung adenocarcinoma.
Fan T; Lu J; Niu D; Zhang Y; Wang B; Zhang B; Zhang Z; He X; Peng N; Li B; Fang H; Gong Z; Zhang L
Front Immunol; 2022; 13():1046121. PubMed ID: 36483553
[TBL] [Abstract][Full Text] [Related]
17. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
19. Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma.
Liu J; Shen H; Gu W; Zheng H; Wang Y; Ma G; Du J
Front Immunol; 2022; 13():960738. PubMed ID: 36032135
[TBL] [Abstract][Full Text] [Related]
20. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]